0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tuberculosis Therapeutics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-22K13059
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Tuberculosis Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Tuberculosis Therapeutics Market Research Report 2024

Code: QYRE-Auto-22K13059
Report
January 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tuberculosis Therapeutics Market Size

The global Tuberculosis Therapeutics market was valued at US$ 840.1 million in 2023 and is anticipated to reach US$ 1061 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

Tuberculosis Therapeutics Market

Tuberculosis Therapeutics Market

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Therapeutics.

Report Scope

The Tuberculosis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tuberculosis Therapeutics Market Report

Report Metric Details
Report Name Tuberculosis Therapeutics Market
Accounted market size in 2023 US$ 840.1 million
Forecasted market size in 2030 US$ 1061 million
CAGR 2.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Isoniazid
  • Rifampin
  • Pyrazinamide
  • Hydrazine Derivatives
  • Miscellaneous Anti-Tubercular Drugs
  • Ethambutol
  • Others
Segment by Application
  • Hospital
  • Pharmacy
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aventis Pharmaceuticals, Sanofi -Aventis, Versapharma Incorporated, Sigma Pharmaceutical Pty, Novartis AG, Hoffmann-La Roche, Bayer Health Care
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tuberculosis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Tuberculosis Therapeutics Market growing?

Ans: The Tuberculosis Therapeutics Market witnessing a CAGR of 2.9% during the forecast period 2024-2030.

What is the Tuberculosis Therapeutics Market size in 2030?

Ans: The Tuberculosis Therapeutics Market size in 2030 will be US$ 1061 million.

Who are the main players in the Tuberculosis Therapeutics Market report?

Ans: The main players in the Tuberculosis Therapeutics Market are Aventis Pharmaceuticals, Sanofi -Aventis, Versapharma Incorporated, Sigma Pharmaceutical Pty, Novartis AG, Hoffmann-La Roche, Bayer Health Care

What are the Application segmentation covered in the Tuberculosis Therapeutics Market report?

Ans: The Applications covered in the Tuberculosis Therapeutics Market report are Hospital, Pharmacy, Clinics, Others

What are the Type segmentation covered in the Tuberculosis Therapeutics Market report?

Ans: The Types covered in the Tuberculosis Therapeutics Market report are Isoniazid, Rifampin, Pyrazinamide, Hydrazine Derivatives, Miscellaneous Anti-Tubercular Drugs, Ethambutol, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Pyrazinamide
1.2.5 Hydrazine Derivatives
1.2.6 Miscellaneous Anti-Tubercular Drugs
1.2.7 Ethambutol
1.2.8 Others
1.3 Market by Application
1.3.1 Global Tuberculosis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Therapeutics Market Perspective (2019-2030)
2.2 Tuberculosis Therapeutics Growth Trends by Region
2.2.1 Global Tuberculosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tuberculosis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Tuberculosis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Tuberculosis Therapeutics Market Dynamics
2.3.1 Tuberculosis Therapeutics Industry Trends
2.3.2 Tuberculosis Therapeutics Market Drivers
2.3.3 Tuberculosis Therapeutics Market Challenges
2.3.4 Tuberculosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Therapeutics Players by Revenue
3.1.1 Global Top Tuberculosis Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Tuberculosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Therapeutics Revenue
3.4 Global Tuberculosis Therapeutics Market Concentration Ratio
3.4.1 Global Tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Therapeutics Revenue in 2023
3.5 Tuberculosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Tuberculosis Therapeutics Product Solution and Service
3.7 Date of Enter into Tuberculosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Therapeutics Breakdown Data by Type
4.1 Global Tuberculosis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Tuberculosis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Tuberculosis Therapeutics Breakdown Data by Application
5.1 Global Tuberculosis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Tuberculosis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tuberculosis Therapeutics Market Size (2019-2030)
6.2 North America Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tuberculosis Therapeutics Market Size by Country (2019-2024)
6.4 North America Tuberculosis Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Therapeutics Market Size (2019-2030)
7.2 Europe Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tuberculosis Therapeutics Market Size by Country (2019-2024)
7.4 Europe Tuberculosis Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Tuberculosis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis Therapeutics Market Size (2019-2030)
9.2 Latin America Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tuberculosis Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Tuberculosis Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Tuberculosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aventis Pharmaceuticals
11.1.1 Aventis Pharmaceuticals Company Detail
11.1.2 Aventis Pharmaceuticals Business Overview
11.1.3 Aventis Pharmaceuticals Tuberculosis Therapeutics Introduction
11.1.4 Aventis Pharmaceuticals Revenue in Tuberculosis Therapeutics Business (2019-2024)
11.1.5 Aventis Pharmaceuticals Recent Development
11.2 Sanofi -Aventis
11.2.1 Sanofi -Aventis Company Detail
11.2.2 Sanofi -Aventis Business Overview
11.2.3 Sanofi -Aventis Tuberculosis Therapeutics Introduction
11.2.4 Sanofi -Aventis Revenue in Tuberculosis Therapeutics Business (2019-2024)
11.2.5 Sanofi -Aventis Recent Development
11.3 Versapharma Incorporated
11.3.1 Versapharma Incorporated Company Detail
11.3.2 Versapharma Incorporated Business Overview
11.3.3 Versapharma Incorporated Tuberculosis Therapeutics Introduction
11.3.4 Versapharma Incorporated Revenue in Tuberculosis Therapeutics Business (2019-2024)
11.3.5 Versapharma Incorporated Recent Development
11.4 Sigma Pharmaceutical Pty
11.4.1 Sigma Pharmaceutical Pty Company Detail
11.4.2 Sigma Pharmaceutical Pty Business Overview
11.4.3 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Introduction
11.4.4 Sigma Pharmaceutical Pty Revenue in Tuberculosis Therapeutics Business (2019-2024)
11.4.5 Sigma Pharmaceutical Pty Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Tuberculosis Therapeutics Introduction
11.5.4 Novartis AG Revenue in Tuberculosis Therapeutics Business (2019-2024)
11.5.5 Novartis AG Recent Development
11.6 Hoffmann-La Roche
11.6.1 Hoffmann-La Roche Company Detail
11.6.2 Hoffmann-La Roche Business Overview
11.6.3 Hoffmann-La Roche Tuberculosis Therapeutics Introduction
11.6.4 Hoffmann-La Roche Revenue in Tuberculosis Therapeutics Business (2019-2024)
11.6.5 Hoffmann-La Roche Recent Development
11.7 Bayer Health Care
11.7.1 Bayer Health Care Company Detail
11.7.2 Bayer Health Care Business Overview
11.7.3 Bayer Health Care Tuberculosis Therapeutics Introduction
11.7.4 Bayer Health Care Revenue in Tuberculosis Therapeutics Business (2019-2024)
11.7.5 Bayer Health Care Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Tuberculosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Isoniazid
    Table 3. Key Players of Rifampin
    Table 4. Key Players of Pyrazinamide
    Table 5. Key Players of Hydrazine Derivatives
    Table 6. Key Players of Miscellaneous Anti-Tubercular Drugs
    Table 7. Key Players of Ethambutol
    Table 8. Key Players of Others
    Table 9. Global Tuberculosis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Tuberculosis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Tuberculosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Tuberculosis Therapeutics Market Share by Region (2019-2024)
    Table 13. Global Tuberculosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Tuberculosis Therapeutics Market Share by Region (2025-2030)
    Table 15. Tuberculosis Therapeutics Market Trends
    Table 16. Tuberculosis Therapeutics Market Drivers
    Table 17. Tuberculosis Therapeutics Market Challenges
    Table 18. Tuberculosis Therapeutics Market Restraints
    Table 19. Global Tuberculosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Tuberculosis Therapeutics Market Share by Players (2019-2024)
    Table 21. Global Top Tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Therapeutics as of 2023)
    Table 22. Ranking of Global Top Tuberculosis Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 23. Global 5 Largest Players Market Share by Tuberculosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Tuberculosis Therapeutics Product Solution and Service
    Table 26. Date of Enter into Tuberculosis Therapeutics Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Tuberculosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Tuberculosis Therapeutics Revenue Market Share by Type (2019-2024)
    Table 30. Global Tuberculosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Tuberculosis Therapeutics Revenue Market Share by Type (2025-2030)
    Table 32. Global Tuberculosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Tuberculosis Therapeutics Revenue Market Share by Application (2019-2024)
    Table 34. Global Tuberculosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Tuberculosis Therapeutics Revenue Market Share by Application (2025-2030)
    Table 36. North America Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Europe Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 41. Europe Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Asia-Pacific Tuberculosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 44. Asia-Pacific Tuberculosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 45. Latin America Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Latin America Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Latin America Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Middle East & Africa Tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Middle East & Africa Tuberculosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 51. Aventis Pharmaceuticals Company Detail
    Table 52. Aventis Pharmaceuticals Business Overview
    Table 53. Aventis Pharmaceuticals Tuberculosis Therapeutics Product
    Table 54. Aventis Pharmaceuticals Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 55. Aventis Pharmaceuticals Recent Development
    Table 56. Sanofi -Aventis Company Detail
    Table 57. Sanofi -Aventis Business Overview
    Table 58. Sanofi -Aventis Tuberculosis Therapeutics Product
    Table 59. Sanofi -Aventis Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 60. Sanofi -Aventis Recent Development
    Table 61. Versapharma Incorporated Company Detail
    Table 62. Versapharma Incorporated Business Overview
    Table 63. Versapharma Incorporated Tuberculosis Therapeutics Product
    Table 64. Versapharma Incorporated Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 65. Versapharma Incorporated Recent Development
    Table 66. Sigma Pharmaceutical Pty Company Detail
    Table 67. Sigma Pharmaceutical Pty Business Overview
    Table 68. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product
    Table 69. Sigma Pharmaceutical Pty Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 70. Sigma Pharmaceutical Pty Recent Development
    Table 71. Novartis AG Company Detail
    Table 72. Novartis AG Business Overview
    Table 73. Novartis AG Tuberculosis Therapeutics Product
    Table 74. Novartis AG Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 75. Novartis AG Recent Development
    Table 76. Hoffmann-La Roche Company Detail
    Table 77. Hoffmann-La Roche Business Overview
    Table 78. Hoffmann-La Roche Tuberculosis Therapeutics Product
    Table 79. Hoffmann-La Roche Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 80. Hoffmann-La Roche Recent Development
    Table 81. Bayer Health Care Company Detail
    Table 82. Bayer Health Care Business Overview
    Table 83. Bayer Health Care Tuberculosis Therapeutics Product
    Table 84. Bayer Health Care Revenue in Tuberculosis Therapeutics Business (2019-2024) & (US$ Million)
    Table 85. Bayer Health Care Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tuberculosis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Tuberculosis Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Isoniazid Features
    Figure 4. Rifampin Features
    Figure 5. Pyrazinamide Features
    Figure 6. Hydrazine Derivatives Features
    Figure 7. Miscellaneous Anti-Tubercular Drugs Features
    Figure 8. Ethambutol Features
    Figure 9. Others Features
    Figure 10. Global Tuberculosis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global Tuberculosis Therapeutics Market Share by Application: 2023 VS 2030
    Figure 12. Hospital Case Studies
    Figure 13. Pharmacy Case Studies
    Figure 14. Clinics Case Studies
    Figure 15. Others Case Studies
    Figure 16. Tuberculosis Therapeutics Report Years Considered
    Figure 17. Global Tuberculosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Tuberculosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Tuberculosis Therapeutics Market Share by Region: 2023 VS 2030
    Figure 20. Global Tuberculosis Therapeutics Market Share by Players in 2023
    Figure 21. Global Top Tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Therapeutics as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Tuberculosis Therapeutics Revenue in 2023
    Figure 23. North America Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Tuberculosis Therapeutics Market Share by Country (2019-2030)
    Figure 25. United States Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Tuberculosis Therapeutics Market Share by Country (2019-2030)
    Figure 29. Germany Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Asia-Pacific Tuberculosis Therapeutics Market Share by Region (2019-2030)
    Figure 37. China Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Japan Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. South Korea Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Southeast Asia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. India Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Australia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Latin America Tuberculosis Therapeutics Market Share by Country (2019-2030)
    Figure 45. Mexico Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Brazil Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Tuberculosis Therapeutics Market Share by Country (2019-2030)
    Figure 49. Turkey Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Tuberculosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Aventis Pharmaceuticals Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)
    Figure 52. Sanofi -Aventis Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)
    Figure 53. Versapharma Incorporated Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)
    Figure 54. Sigma Pharmaceutical Pty Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)
    Figure 55. Novartis AG Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)
    Figure 56. Hoffmann-La Roche Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)
    Figure 57. Bayer Health Care Revenue Growth Rate in Tuberculosis Therapeutics Business (2019-2024)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Tuberculosis (TB) Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9U6180
Wed Feb 07 00:00:00 UTC 2024

Add to Cart

Global Cattle Respiratory Vaccines Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2P2887
Wed Feb 07 00:00:00 UTC 2024

Add to Cart

Global Pseudorabies Virus Vaccine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14B9979
Tue Feb 06 00:00:00 UTC 2024

Add to Cart

Global Human Hepatitis B Immunoglobulin Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31R4120
Mon Feb 05 00:00:00 UTC 2024

Add to Cart